Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures

Abstract

The aging population worldwide is facing a significant increase in age-related non-communicable diseases, including cardiovascular and brain pathologies. This comprehensive review paper delves into the impact of the exposome, which encompasses the totality of environmental exposures, on unhealthy aging. It explores how environmental factors contribute to the acceleration of aging processes, increase biological age, and facilitate the development and progression of a wide range of age-associated diseases. The impact of environmental factors on cognitive health and the development of chronic age-related diseases affecting the cardiovascular system and central nervous system is discussed, with a specific focus on Alzheimer’s disease, Parkinson’s disease, stroke, small vessel disease, and vascular cognitive impairment (VCI). Aging is a major risk factor for these diseases. Their pathogenesis involves cellular and molecular mechanisms of aging such as increased oxidative stress, impaired mitochondrial function, DNA damage, and inflammation and is influenced by environmental factors. Environmental toxicants, including ambient particulate matter, pesticides, heavy metals, and organic solvents, have been identified as significant contributors to cardiovascular and brain aging disorders. These toxicants can inflict both macro- and microvascular damage and many of them can also cross the blood–brain barrier, inducing neurotoxic effects, neuroinflammation, and neuronal dysfunction. In conclusion, environmental factors play a critical role in modulating cardiovascular and brain aging. A deeper understanding of how environmental toxicants exacerbate aging processes and contribute to the pathogenesis of neurodegenerative diseases, VCI, and dementia is crucial for the development of preventive strategies and interventions to promote cardiovascular, cerebrovascular, and brain health. By mitigating exposure to harmful environmental factors and promoting healthy aging, we can strive to reduce the burden of age-related cardiovascular and brain pathologies in the aging population.

Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol

“…The median age of patients experiencing AHA onset due to drug exposure is typically around the age of 75 years [ 10 ]. The increased prevalence of autoimmunity in older individuals may be attributed to several factors related to the aging process, including immunosenescence [ 35 ], chronic low-grade sterile inflammation (“inflammaging” [ 36 , 37 ]), cumulative environmental exposure [ 38 ], clonal hematopoiesis of indeterminate potential (CHIP) [ 39 ], age-related thymus involution and hormonal changes. Importantly, there is generally a median period of about 30 days from the start of the implicated medication to the emergence of AHA symptoms [ 10 ].…”

Geroscience and pathology: a new frontier in understanding age-related diseases

“…These factors, emanating from the central nervous system, endocrine organs, the immune system, adipose tissue, and even the gastrointestinal tract, play pivotal roles in orchestrating and harmonizing aging processes. An important implication of this concept is that conventional risk factors (including lifestyle [44][45][46][47][48][49][50] and environmental risk factors [51,52]) exacerbate age-related pathologies by intensifying fundamental molecular and cellular aging processes, both cell autonomous and non-cell autonomous.…”

2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?

“…Exposures to criteria air pollutants (ground-level ozone, particulate matter, nitrogen dioxide, sulfur dioxide, carbon monoxide, lead) as specified by the Environmental Protection Agency (EPA) in the United States (US) [1] and other environmental toxicants cause detrimental brain effects, starting in utero [2][3][4][5][6][7][8][9]. We have shown anthro-pogenic ultrafine particulate matter (UFPM) and industrial and natural nanoparticles (NPs) are present in normal term, preeclamptic, and early postconceptional human placentas from women residing in polluted Mexican cities [9].…”